| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |